Skip to main content

Eurostars — Portfolio, Page 2

Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.

68
Companies
$216.4M
Total invested
$4.9M
Avg. check
33
Industries
Biotechnology 12Health Care 9Medical 5Artificial Intelligence (AI) 5Pharmaceutical 5Software 4+27 more
Founder contacts

Verified emails & LinkedIn for founders across this portfolio.

jane@on●●●●●●●.com
linkedin.com/in/●●●●●●
Verified contacts, updated monthly
Get instant access →

Portfolio companies

Showing 2548 of 68
Age Labs
December 2024

Age Labs is a molecular diagnostics company focused on reducing the cost of developing drugs by accurately measuring your biological age.

Biotechnology · OsloGrant
Wenemea
January 2026

Wenemea is the developer of chemotherapy-induced peripheral neuropathy designed for cancer treatment through neurological screening.

Medical · Aarhus$1.1M Grant
Simularge
December 2025

Plug & play autopilot for manufacturing machines with deep-tech AI ( Digital Twin, SaaS)

Artificial Intelligence (AI) · Palo Alto$117K Grant
Bio-Sourcing
January 2026

BioSourcing is developing a New Generation of Biotherapeutics, in particular Monoclonal Antibodies for Global Unmet Medical Needs

Biotechnology · LiègeGrant
WSK Medical
January 2025

First AI platform on the market for real-time detection and classification of Head and Neck cancers and benign lesions.

Artificial Intelligence (AI) · Amsterdam$168K Grant
Renalyse
October 2023

Renalyse is the registered trade name of CreatSens Health S.L., a biotechnology company focusing on the development of medical platforms.

Medical · Tarragona$1.1M Venture - Series Unknown
Magnes
October 2024

Magnes, has developed a disruptive real-life-monitoring solution to analyze walk patterns of patients with neurological disorders.

Consulting · ZürichGrant
Polar Light Technologies
March 2026

Polar Light Technologies focuses on developing the next generation of Nano and micro LED technology.

Lighting · LinköpingGrant
InVirtuoLabs
February 2026

InVirtuoLabs is a firm that uses artificial intelligence and molecular simulations to transform drug discovery.

Artificial Intelligence (AI) · Lugano$2.7M Grant
NEOGAP Therapeutics
February 2026

NEOGAP Therapeutics is a Pharmaceutical manufacturing industry.

Biotechnology · Stockholm$9.8M Series Unknown
ProVascTec
September 2025

ProVascTec is a preclinical stage cell treatment firm, to stimulate the development of a novel circulatory system.

Biotechnology · Cork$2.9M Grant
Sensars
September 2025

Sensars restores natural foot sensation in diabetics, preventing ulcers and amputations with neuromodulation.

Diabetes · West GroveSeed
INERGIO
September 2025

INERGIO is a reliable power power supply yet is a challenge to off-grid systems.

Environmental Consulting · LausanneGrant
Broken String Biosciences
July 2025

Broken String Biosciences is developing a platform of novel sequencing tools to assess genome stability and to unlock the next generation.

Biotechnology · CambridgeGrant
LenioBio
July 2025

LenioBio develops rapid plant-based, cell-free protein expression that scales for research, development and production.

Biotechnology · Düsseldorf$4.4M Grant
Cellevate
April 2025

Cellevate is an innovative biotech company that develops the next generation of cell culture systems.

Biotechnology · LundGrant
NOVIGENIX
March 2025

Novigenix is a precision medicine company that specializes in ImmunoTranscriptomic solutions.

Artificial Intelligence (AI) · Epalinges$1.9M Grant
Onena Medicines
March 2025

Onena Medicines is a biotechnology company provides medical devices, antibodies to treat cancer and rare diseases.

Biotechnology · Donostia-san SebastiánConvertible Note
bNovate Technologies
February 2025

BNovate Technologies develops automated water monitoring solutions, specializing in microbiological analysis through flow cytometry.

Biotechnology · Ecublens$4.2M Grant
Perciv AI
December 2024

Perciv offers AI based software solutions to unleash the hidden capabilities of radars and enable robust autonomous systems.

Artificial Intelligence (AI) · Delft$2.6M Seed
Brenus Pharma
September 2024

Brenus Pharma is an allogeneic platform to generate immune therapy ambitioning to harness patient immune system & prevent cancer resistance.

Biotechnology · Issoire$25.0M Series A
Vandria
August 2024

Vandria creates mitophagy inducers that renew cells to address ageing and chronic disorders.

Manufacturing · Lausanne$10.1M Series A
Smart Reporting
April 2024

Smart Reporting is a digital health start-up that provides documentation software in the medical field.

Health Care · Munich$24.5M Series C
Hemotune
March 2024

Hemotune is a medical device company that develops a therapeutic blood purification platform for the treatment of health ailments.

Biotechnology · Schlieren$15.6M Series B

Where Eurostars invests

Biotechnology12
Health Care9
Medical5
Artificial Intelligence (AI)5
Pharmaceutical5
Software4

About Eurostars's portfolio

How many companies has Eurostars invested in?

Eurostars has invested in 68 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.

What industries does Eurostars invest in?

Eurostars's top investment sectors include Biotechnology, Health Care, Medical, Artificial Intelligence (AI), Pharmaceutical. The firm invests across 33 different industry categories.

What is Eurostars's largest investment?

Among tracked funding rounds, Brenus Pharma received $25.0M in a Series A round. Eurostars's total known invested capital is $216.4M.

What is the average investment size for Eurostars?

Eurostars's average investment size is $4.9M across its portfolio of 68 companies.

What are Eurostars's most recent investments?

Recent Eurostars portfolio additions include Age Labs, Wenemea, Simularge, Bio-Sourcing, WSK Medical. These companies were founded in 2020 or later.

Reach the founders behind these 68 companies
Verified emails and LinkedIn profiles, updated monthly.
Get instant access →